FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: A potential diagnostic tool

American Journal of Dermatopathology

Volumn 33, Issue 2, 2011, Pages 140-143

  Patel, Rajiv M ^a,b   Downs Kelly, Erinn ^c   Dandekar, Monisha N ^a   Fanburg Smith, Julie C ^d   Billings, Steven D ^c   Tubbs, Raymond R ^e   Goldblum, John R ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c Departments of Anatomic Pathology   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

fluorescence in situ hybridization; FUS CREB3L2; hyalinizing spindle cell tumor with giant rosettes; Low grade fibromyxoid sarcoma

Indexed keywords

FORMALDEHYDE; PARAFFIN;

ARTICLE; CANCER GRADING; CELL NUCLEUS; CLINICAL ARTICLE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FIBROMYXOID SARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE PROBE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MALIGNANT FIBROUS HISTIOCYTOMA; MYXOMA; PRIORITY JOURNAL; SARCOMA; SOFT TISSUE TUMOR; TISSUE SECTION;

EID: 85027934549     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318176de80     Document Type: Article

References (15)

1. Evans HL. Low-grade fibromyxoid sarcoma. A report of two metasta-sizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987;88:615-619. (Pubitemid 18014621)
2. Folpe AL, Lane KL, Paull G, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol. 2000;24:1353-1360.
3. Devaney DM, Dervan P, O'Neill S, et al. Low-grade fibromyxoid sarcoma. Histopathology. 1990;17:463-465.
4. Evans HL. Low-grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol. 1993;17:595-600. (Pubitemid 23152597)
5. Goodlad JR, Mentzel T, Fletcher CD. Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histopathology. 1995;26:229-237.
6. Lane KL, Shannon RJ, Weiss SW. Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am J Surg Pathol. 1997;21:1481-1488. (Pubitemid 27528259)
7. Reid R, de Silva MV, Paterson L, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16)(q34;p11) translocation. Am J Surg Pathol. 2003;27:1229-1236. (Pubitemid 37040585)
8. Storlazzi CT, Mertens F, Nascimento A, et al. Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma. Hum Mol Genet. 2003; 12:2349-2358. (Pubitemid 37160879)
9. Mertens F, Fletcher CD, Antonescu CR, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85: 408-415. (Pubitemid 40333157)
10. Billings SD, Giblen G, Fanburg-Smith JC Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol. 2005;29:204-210. (Pubitemid 40170638)
11. Patel RM, Downs-Kelly E, Weiss SW, et al. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol. 2005;18:1585-1590. (Pubitemid 41670657)
12. Downs-Kelly E, Goldblum JR, Patel RM, et al. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol. 2008;32:8-13.
13. Guillou L, Benhattar J, Gengler C, et al. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relation-ship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol. 2007;31:1387-1402. (Pubitemid 47329676)
14. Matsuyama A, Hisaoka M, Shimajiri S, et al. Molecular detection ofFUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Am J Surg Pathol. 2006;30:1077-1084. (Pubitemid 44299339)
15. Panagopoulos I, Storlazzi CT, Fletcher CD, et al. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer. 2004;40:218-228. (Pubitemid 38703098)